Budapest, Hungary

Péter Trinka

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Péter Trinka in Pharmaceutical Chemistry

Introduction

Péter Trinka is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that influence the central nervous system and the heart. His research has led to the development of novel derivatives that hold promise for medical applications.

Latest Patents

Péter Trinka holds a patent for his invention titled "2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the C.N.S. and the heart." This patent describes a series of novel compounds that have a significant impact on both the heart and the central nervous system. The invention includes pharmaceutical compositions containing these derivatives and outlines a process for their preparation. The compounds are characterized by specific structural formulas that allow for various substitutions, enhancing their therapeutic potential.

Career Highlights

Throughout his career, Trinka has focused on the synthesis and application of chemical compounds that can be used in medical treatments. His work has been recognized for its innovative approach to addressing complex health issues. With a patent portfolio that includes one significant patent, he continues to contribute to advancements in pharmaceutical science.

Collaborations

Péter Trinka has collaborated with esteemed colleagues such as József Reiter and József Barkóczy. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Péter Trinka's contributions to the field of pharmaceutical chemistry exemplify the importance of innovation in developing new medical treatments. His patented work on 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives showcases his commitment to advancing healthcare through scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…